Literature DB >> 19467387

Infliximab treatment for severe psoriasis in a patient with active hepatitis B virus infection.

Alberto Conde-Taboada, Javier Pedraz Muñoz, Lucía Campos Muñoz, Eduardo López-Bran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19467387     DOI： 10.1016/j.jaad.2008.09.057

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

Review 3.  Reactivation of hepatitis B virus infection after cytotoxic chemotherapy or immunosuppressive therapy.

Authors:  María Luisa Manzano-Alonso; Gregorio Castellano-Tortajada
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

4.  Risk of Hepatitis B Reactivation in Patients with Psoriasis on Ustekinumab.

Authors:  Sze-Wen Ting; Yi-Cheng Chen; Yu-Huei Huang
Journal:  Clin Drug Investig       Date:  2018-09       Impact factor: 2.859

Review 5.  Liver Illness and Psoriatic Patients.

Authors:  Marco Fiore; Sebastiano Leone; Alberto Enrico Maraolo; Emilio Berti; Giovanni Damiani
Journal:  Biomed Res Int       Date:  2018-02-06       Impact factor: 3.411
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.